Accelerate Diagnostics Inc AXDX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AXDX is a good fit for your portfolio.
News
-
Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results
-
Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results.
-
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results
-
Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results.
Trading Information
- Previous Close Price
- $0.87
- Day Range
- $0.92–0.94
- 52-Week Range
- $0.73–11.90
- Bid/Ask
- $0.88 / $0.94
- Market Cap
- $20.04 Mil
- Volume/Avg
- 3,675 / 60,760
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.90
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 134
Comparables
Valuation
|
Metric
|
AXDX
|
TIHE
|
688399
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 9.69 |
Price/Book Value | — | — | 1.28 |
Price/Sales | 0.90 | — | 10.99 |
Price/Cash Flow | — | — | 26.49 |
Price/Earnings
AXDX
TIHE
688399
Financial Strength
|
Metric
|
AXDX
|
TIHE
|
688399
|
|---|---|---|---|
Quick Ratio | 1.32 | — | 5.60 |
Current Ratio | 2.03 | — | 6.05 |
Interest Coverage | −6.99 | — | 7.11 |
Quick Ratio
AXDX
TIHE
688399
Profitability
|
Metric
|
AXDX
|
TIHE
|
688399
|
|---|---|---|---|
Return on Assets (Normalized) | −97.06% | — | −8.92% |
Return on Equity (Normalized) | — | — | −10.60% |
Return on Invested Capital (Normalized) | −179.51% | — | −11.13% |
Return on Assets
AXDX
TIHE
688399
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Hllwvzrx | Mnvkvw | $182.6 Bil | |
SYK
| Stryker Corp | Fjpbjrqzd | Chlrt | $126.0 Bil | |
MDT
| Medtronic PLC | Zyjycjfp | Zmrcbyz | $108.3 Bil | |
BSX
| Boston Scientific Corp | Vhwvyjnv | Xcwhghj | $106.9 Bil | |
EW
| Edwards Lifesciences Corp | Dzlcncwjpn | Bwrlcy | $51.7 Bil | |
DXCM
| DexCom Inc | Kryfwgyb | Nbnv | $50.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Fjpmfkkqxj | Rsplk | $24.9 Bil | |
PHG
| Koninklijke Philips NV ADR | Wcbvgmh | Bpqpvr | $23.9 Bil | |
ALGN
| Align Technology Inc | Pmvczsk | Fygfct | $21.1 Bil | |
PODD
| Insulet Corp | Vbzfpqkxrx | Xvkjrq | $12.4 Bil |